⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8

Every month we try and update this database with for postneoadjuvant therapy stage ivb gastroesophageal junction adenocarcinoma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsNCT04771520
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Mali...
Metastatic Mela...
Metastatic Prim...
Metastatic Sarc...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Prognostic Stag...
Prognostic Stag...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Avapritinib
18 Years - M.D. Anderson Cancer Center
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerNCT04511039
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Metastatic Colo...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Trifluridine an...
Talazoparib Tos...
18 Years - Roswell Park Cancer Institute
Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersNCT04221893
Stage IV Esopha...
Stage IV Esopha...
Stage IV Gastri...
Stage IV Adenoc...
Stage IVA Esoph...
Stage IVA Esoph...
Stage IVA Gastr...
Stage IVA Adeno...
Stage IVB Esoph...
Stage IVB Esoph...
Stage IVB Gastr...
Stage IVB Gastr...
Metastatic Anal...
Metastatic Colo...
Metastatic Esop...
Metastatic Gast...
Metastatic Gast...
Metastatic Hepa...
Metastatic Mali...
Metastatic Smal...
Pancreatobiliar...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage IV Anal C...
Stage IV Colore...
Stage IV Hepato...
Stage IVA Color...
Stage IVA Hepat...
Stage IVB Color...
Stage IVB Hepat...
Stage IVC Color...
Radiation Thera...
18 Years - University of California, San Francisco
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal AdenocarcinomaNCT05041153
Advanced Gastri...
Advanced Gastro...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Gast...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Unresectable Ga...
Unresectable Ga...
Lenvatinib
Pembrolizumab
18 Years - M.D. Anderson Cancer Center
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerNCT04511039
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Metastatic Colo...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Trifluridine an...
Talazoparib Tos...
18 Years - Roswell Park Cancer Institute
Paclitaxel for the Treatment of Gastric or Gastroesophageal CancerNCT04220827
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Gast...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Peritoneal Carc...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Paclitaxel
18 Years - M.D. Anderson Cancer Center
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal CancerNCT04522336
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Localized Gastr...
Locally Advance...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Unresectable Ga...
Docetaxel
Fluorouracil
Oxaliplatin
Pembrolizumab
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction CancersNCT04460937
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Distal Esophagu...
Gastric Cardia ...
Metastatic Esop...
Metastatic Esop...
Metastatic Gast...
Metastatic Mali...
Metastatic Mali...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Unresectable Es...
Unresectable Es...
Unresectable Es...
Unresectable Ga...
Adavosertib
Radiation Thera...
18 Years - National Cancer Institute (NCI)
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal CancerNCT04522336
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Localized Gastr...
Locally Advance...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Unresectable Ga...
Docetaxel
Fluorouracil
Oxaliplatin
Pembrolizumab
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerNCT03918499
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Gast...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Recurrent Gastr...
Recurrent Gastr...
Cyclophosphamid...
Cytokine-based ...
Pembrolizumab
18 Years - City of Hope Medical Center
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction CancerNCT04660760
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Metastatic Gast...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Paclitaxel
Quality-of-Life...
Ramucirumab
Trifluridine an...
18 Years - Academic and Community Cancer Research United
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: